We are de-risking biomedical innovation, turning biomedical knowledge into social and economic value.
More than three decades later, we remain committed in pursuit of pharmaceutical innovation, providing high quality products and striving to deliver superior business results.
The patient is at the heart of what we do, making decisions regarding biometric innovation is usually a complicated and chaotic procedure as it consists of various product options, various facets to ascertain these on, and multiple evaluations at all levels.
Discover our therapeutic areas, where we continuously invest to innovate and deliver therapeutic solutions for patient’s benefit.
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more
17
Jun 2026
Physicians and researchers at the Netherlands Cancer Institute have developed an AI model that outperforms physicians at evaluating treatment response in pleural mesothelioma.
17
Jun 2026
New research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London and published in The Lancet Psychiatry has found that people with psychosis experiencing Post Traumatic Stress Disorder (PTSD) can benefit from a Trauma-Focused therapy integrated with Cognitive Behavior Therapy for psychosis (CBTp).
17
Jun 2026
Removing criminal penalties for possessing cannabis for personal use, or introducing tightly controlled legalisation of cannabis, does not appear to increase levels of cannabis use.
17
Jun 2026
Researchers at Cedars-Sinai Health Sciences University and Johns Hopkins University have identified genetic mutations that may explain why some people develop a spontaneous cerebrospinal fluid (CSF) leak in the spine.